PGP9.5: a marker for cellular neurothekeoma.

Area of Science:

• Dermatopathology
• Surgical Pathology
• Oncology

Background:

• Neurothekeomas are benign cutaneous neoplasms with debated origins, particularly the cellular type.
• Distinguishing between myxoid, intermediate, and cellular neurothekeoma subtypes is crucial for understanding their pathology.
• Previous studies lacked consistent markers to confirm the neural origin of cellular neurothekeoma.

Purpose of the Study:

• To evaluate the utility of protein gene product 9.5 (PGP9.5) as a neural marker for all neurothekeoma subtypes.
• To investigate the effectiveness of microwave antigen retrieval in enhancing neurothekeoma marker detection.
• To clarify the neural differentiation of cellular neurothekeoma.

Main Methods:

• Immunohistochemical analysis of neurothekeoma samples.
• Utilized microwave antigen retrieval for enhanced protein gene product 9.5 (PGP9.5) and S-100 protein detection.
• Compared PGP9.5 and S-100 protein immunoreactivity across myxoid, intermediate, and cellular neurothekeoma types.

Main Results:

• Protein gene product 9.5 (PGP9.5) demonstrated 100% positivity in cellular neurothekeomas with microwave antigen retrieval.
• All neurothekeoma subtypes (myxoid, intermediate, cellular) showed positive PGP9.5 immunoreactivity.
• S-100 protein positivity was inconsistent in cellular neurothekeomas (3 of 12 cases).

Conclusions:

• Protein gene product 9.5 (PGP9.5) is a highly sensitive and specific marker for diagnosing all neurothekeoma types, including cellular neurothekeoma.
• Microwave antigen retrieval significantly improves the detection of neural markers in neurothekeomas.
• The findings support the neural differentiation of cellular neurothekeoma, resolving previous diagnostic uncertainties.